Weight loss jabs could 'cut risk of heart attack or stroke', new study claims
Marketed as Wegovy, Ozempic and Rybelsus, semaglutide injections may benefit obese patients even if they don't lose weight.
Full Article
Weight loss jabs could 'cut risk of heart attack or stroke', new study claims
Daily Record
0 shares
1 views
You might like
Related news coverage
Weight loss jabs like Ozempic 'could reduceheart attack risk' | BBC News
Rumble
An injection designed to tackle obesity could reducethe risk of heart attacks and strokes - regardless ofhow much weight they lose..
